**Question:** Exfoliative toxin A which causes generalized desquamation is secreted by the following:

A. Staphylococcal exfoliative toxin
B. Streptococcal exfoliative toxin
C. Streptococcal pyoderma antigen preparation (SPAP)
D. Streptococcal pyoderma antigen preparation (SPAP)

**Correct Answer:** D. Streptococcal pyoderma antigen preparation (SPAP)

**Core Concept:** Exfoliative toxins are proteins secreted by certain bacteria that cause the desquamation (peeling) of skin cells by disrupting the desmosomal junctions, leading to generalized skin shedding.

**Why the Correct Answer is Right:** Exfoliative toxin A is a protein secreted by certain strains of Streptococcus pyogenes, a bacterium that causes scarlet fever and streptococcal skin infections. When exfoliative toxin A enters the skin, it specifically targets and breaks down desmoglein 1, a protein located in desmosomes, which are cell adhesion structures involved in maintaining the integrity of the skin barrier. This leads to the characteristic skin peeling seen in conditions like toxic epidermal necrolysis (SJS) and epidermolysis bullosa acquisita (EBA).

**Why Each Wrong Option is Incorrect:**

A. Staphylococcal exfoliative toxin: Staphylococcus aureus produces exfoliative toxin B, not A. Exfoliative toxin A is associated with Streptococcus pyogenes.

B. Streptococcal exfoliative toxin: As explained earlier, exfoliative toxin A is produced by Streptococcus pyogenes, not Streptococcus pyoderma.

C. Streptococcal pyoderma antigen preparation (SPAP): This option is incorrect because SPAP is a preparation containing antigens from Streptococcus pyoderma, not the actual toxin responsible for exfoliative dermatitis.

**Clinical Pearl:** Exfoliative dermatitis is a severe skin reaction characterized by epidermal cell detachment, which can be caused by exfoliative toxins from either Staphylococcus aureus or Streptococcus pyogenes. Infections with these bacteria should be suspected in patients presenting with exfoliative dermatitis and proper management should take into account the causative agent to prevent complications and improve patient outcomes.